Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159

NCT05082779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Primary Sclerosing Cholangitis (PSC)

Interventions

DRUG: CS0159

Sponsor

Cascade Pharmaceuticals, Inc

Collaborators

[object Object]